FABP4 and metabolic dysfunction-associated steatotic liver disease: In individuals with NAFLD, hepatic FABP1, FABP4, and FABP5 mRNA levels were increased compared to non-NAFLD controls, and FABP4 and FABP5 expression were correlated with the percentage of fat in the liver [89,91].